EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Paracetamol use prior to and in early pregnancy: Prevalence and patterns among women with and without chronic medical diseases

Mille Taagaard iD, Line Rode, Mie Gaarskjaer de Wolff, Peter Damm, Casper P Hagen, Margit Bistrup Fisher, Hanne Kristine Hegaard, Ane Lilleøre Rom iD

British Journal of Clinical Pharmacology · 2023-08 · 89 (8) · 2582-2591

DOI: 10.1111/bcp.15732 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 18.04.2023. Verfasst von Mille Taagaard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, The Juliane Marie Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Mental Disorders, Migraine Disorders. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Paracetamol is commonly consumed by pregnant women, even though recent data have questioned its safety. Having chronic medical diseases (CMDs) may influence the prevalence of use during pregnancy. We aimed to assess the prevalence and patterns of use 3 months prior to pregnancy and in the first trimester among women with and without CMDs and the potential influence of CMDs on frequent use in the first trimester.

Methods

We used patient‐reported data from the Copenhagen Pregnancy Cohort from 1 October 2013 to 23 May 2019 with information on CMDs and paracetamol use. Prevalence and patterns of use were assessed descriptively and by multivariable logistic regression models.

Results

We included 24 019 pregnancies. Use of paracetamol prior to and in early pregnancy was significantly higher among women with CMDs compared to women without (40.7% vs . 35.8% and 9.1% vs . 5.1%, respectively). Women with CMDs were 2.7 times more likely to have a frequent intake compared to women without [aOR 2.69 (95% CI 2.05–3.32)]. Migraine, rheumatoid arthritis and mental disease were associated with a higher use of paracetamol [aOR 4.39 (3.20–6.02), aOR 4.32 (2.41–7.72) and aOR 2.74 (1.67–4.49), respectively].

Conclusions

Women with CMDs had a higher paracetamol use before and during pregnancy than women without CMDs. Women with migraine, rheumatoid arthritis and mental disease showed the highest risk of frequent use. This study highlights the importance of discussing pain relief in pregnancy and evaluating the influence of maternal CMDs when assessing adverse effects of paracetamol use during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mental DisordersMigraine DisordersFemalePregnancyHumansAcetaminophenPrevalencePain Management

Stichwörter der Autor:innen

acetaminophenchronic medical diseaseparacetamolpregnancy

Substanzen

Acetaminophen

Autor:innen und Institutionen

  • Department of Obstetrics, The Juliane Marie Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Biochemistry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Obstetrics, Center for Fetal Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Gynaecology and Obstetrics, Copenhagen University Hospital, Amager-Hvidovre, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Mille Taagaard, Ane Lilleøre Rom

Zitieren

APA

Taagaard, M., Rode, L., de Wolff, M. G., Damm, P., Hagen, C. P., Fisher, M. B., Hegaard, H. K., & Rom, A. L. (2023). Paracetamol use prior to and in early pregnancy: Prevalence and patterns among women with and without chronic medical diseases. British Journal of Clinical Pharmacology, 89(8), 2582-2591. https://doi.org/10.1111/bcp.15732

Vancouver

Taagaard M, Rode L, de Wolff MG, Damm P, Hagen CP, Fisher MB, et al. Paracetamol use prior to and in early pregnancy: Prevalence and patterns among women with and without chronic medical diseases. British Journal of Clinical Pharmacology. 2023;89(8):2582-2591. doi:10.1111/bcp.15732

BibTeX
@article{Taagaard2023,
  author = {Taagaard, Mille and Rode, Line and de Wolff, Mie Gaarskjaer and Damm, Peter and Hagen, Casper P and Fisher, Margit Bistrup and Hegaard, Hanne Kristine and Rom, Ane Lilleøre},
  title = {Paracetamol use prior to and in early pregnancy: Prevalence and patterns among women with and without chronic medical diseases},
  journal = {British Journal of Clinical Pharmacology},
  year = {2023},
  volume = {89},
  number = {8},
  pages = {2582--2591},
  doi = {10.1111/bcp.15732}
}
Kostenlos starten →